George Ekow Quaye

Dr. George Ekow Quaye

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2024 in Metabolites
Verified
Journal Article
Open access
PDF file
KHKiana Holbrook
Kiana Holbrook
GQGeorge Ekow Quaye
George Ekow Quaye
ELElizabeth Noriega Landa
Elizabeth Noriega Landa
XSXiaogang Su
Xiaogang Su
QGQin Gao
Qin Gao
WLWen-Yee Lee
Wen-Yee Lee
Background: Clear cell renal cell carcinoma (ccRCC) comprises the majority, approximately 70–80%, of renal cancer cases and often remains asymptomatic until incidentally detected during unrelated abdominal imaging or at advanced stages. Currently, standardized screening tests for renal cancer are lacking, which presents challenges in disease management and improving patient outcomes. This study aimed to identify ccRCC-specific volatile organic compounds (VOCs) in the urine of ccRCC-positive patients and develop a urinary VOC-based diagnostic model. Methods: This study involved 233 pretreatment ccRCC patients and 43 healthy individuals. VOC analysis utilized stir-bar sorptive extraction coupled with thermal desorption gas chromatography/mass spectrometry (SBSE-TD-GC/MS). A ccRCC diagnostic model was established via logistic regression, trained on 163 ccRCC cases versus 31 controls, and validated with 70 ccRCC cases versus 12 controls, resulting in a ccRCC diagnostic model involving 24 VOC markers. Results: The findings demonstrated promising diagnostic efficacy, with an Area Under the Curve (AUC) of 0.94, 86% sensitivity, and 92% specificity. Conclusions: This study highlights the feasibility of using urine as a reliable biospecimen for identifying VOC biomarkers in ccRCC. While further validation in larger cohorts is necessary, this study’s capability to differentiate between ccRCC and control groups, despite sample size limitations, holds significant promise.

9 February 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ELElizabeth Noriega Landa
Elizabeth Noriega Landa
GQGeorge Ekow Quaye
George Ekow Quaye
XSXiaogang Su
Xiaogang Su
SBSabur Badmos
Sabur Badmos
KHKiana L. Holbrook
Kiana L. Holbrook
WLWen-Yee Lee
Wen-Yee Lee
The lack of accuracy in the current prostate specific antigen (PSA) test for prostate cancer (PCa) screening causes around 60–75% of unnecessary prostate biopsies. Therefore, alternative diagnostic methods that have better accuracy and can prevent over-diagnosis of PCa are needed. Researchers have examined various potential biomarkers for PCa, and of those fatty acids (FAs) markers have received special attention due to their role in cancer metabolomics. It has been noted that PCa metabolism prefers FAs over glucose substrates for continued rapid proliferation. Hence, we proposed using a urinary FAs based model as a non-invasive alternative for PCa detection. Urine samples collected from 334 biopsy-designated PCa positive and 232 biopsy-designated PCa negative subjects were analyzed for FAs and lipid related compounds by stir bar sorptive extraction coupled with gas chromatography/mass spectrometry (SBSE-GC/MS). The dataset was split into the training (70%) and testing (30%) sets to develop and validate logit models and repeated for 100 runs of random data partitioning. Over the 100 runs, we confirmed the stability of the models and obtained optimal tuning parameters for developing the final FA based model. A PSA model using the values of the patients’ PSA test results was constructed with the same cohort for the purpose of comparing the performances of the FA model against PSA test. The FA final model selected 20 FAs and rendered an AUC of 0.71 (95% CI = 0.67–0.75, sensitivity = 0.48, and specificity = 0.83). In comparison, the PSA model performed with an AUC of 0.51 (95% CI = 0.46–0.66, sensitivity = 0.44, and specificity = 0.71). The study supports the potential use of urinary FAs as a stable and non-invasive alternative test for PCa diagnosis.

26 April 2024 in Journal of Applied Statistics
Verified
Journal Article
Closed access
GQGeorge Ekow Quaye
George Ekow Quaye
WLWen-Yee Lee
Wen-Yee Lee
ELElizabeth Noriega Landa
Elizabeth Noriega Landa
SBSabur Badmos
Sabur Badmos
KHKiana L. Holbrook
Kiana L. Holbrook
XSXiaogang Su
Xiaogang Su
Early detection of prostate cancer is critical for successful treatment and survival. However, current diagnostic methods such as prostate-specific antigen (PSA) testing and digital rectal examination (DRE) have limitations in accuracy, specificity, and sensitivity. Recent research suggests that urinary volatile organic compounds (VOCs) could serve as potential biomarkers for prostate cancer diagnosis. In this study, urine samples from 337 PCa-positive and 233 PCa-negative patients were collected to develop a diagnosis model. The study involves a high dimensional (HD) classification problem due to the vast number of measured VOCs. Our findings reveal that regularized logistic regression outperforms numerous other classifiers when analyzing the collected data. In particular, we have selected a regularized logistic model with the SCAD (smoothly clipped absolute deviation) penalty as the final model, which attains an AUC (area under the ROC curve) of 0.748, in contrast to a PSA-based AUC of 0.540. These results underscore the potential of VOC-based diagnosis as a clinically feasible approach for PCa screening.

1 January 2024
Verified
Journal Article
Closed access
SBSabur Badmos
Sabur Badmos
ENElizabeth Noriega-Landa
Elizabeth Noriega-Landa
KHKiana L. Holbrook
Kiana L. Holbrook
GQGeorge Ekow Quaye
George Ekow Quaye
XSXiaogang Su
Xiaogang Su
WLWen-Yee Lee
Wen-Yee Lee

11 October 2024 in Mathematics
Verified
Journal Article
Open access
PDF file
XSXiaogang Su
Xiaogang Su
GQGeorge Ekow Quaye
George Ekow Quaye
YWYishu Wei
Yishu Wei
JKJoseph Kang
Joseph Kang
LLLei Liu
Lei Liu
RLRichard Levine
Richard Levine
Greedy search (GS) or exhaustive search plays a crucial role in decision trees and their various extensions. We introduce an alternative splitting method called smooth sigmoid surrogate (SSS) in which the indicator threshold function used in GS is approximated by a smooth sigmoid function. This approach allows for parametric smoothing or regularization of the erratic and discrete GS process, making it more effective in identifying the true cutoff point, particularly in the presence of weak signals, as well as less prone to the inherent end-cut preference problem. Additionally, SSS provides a convenient means of evaluating the best split by referencing a parametric nonlinear model. Moreover, in many variants of recursive partitioning, SSS can be reformulated as a one-dimensional smooth optimization problem, rendering it computationally more efficient than GS. Extensive simulation studies and real data examples are provided to evaluate and demonstrate its effectiveness.

24 August 2025 in Cancers
Verified
Journal Article
Open access
PDF file
SBSabur Badmos
Sabur Badmos
ELElizabeth Noriega Landa
Elizabeth Noriega Landa
KHKiana Holbrook
Kiana Holbrook
GQGeorge Ekow Quaye
George Ekow Quaye
XSXiaogang Su
Xiaogang Su
WLWen-Yee Lee
Wen-Yee Lee
Background/objectives: Prostate cancer (PCa) is the most common cancer among males. Approximately 20–40% of patients with clinically localized PCa will present with a biochemical recurrence after a radical prostatectomy (RP), while some will present with recurrent metastasis. Monitoring the disease post-treatment is crucial for detecting a potential cancer recurrence early. Urinary volatile organic compounds (VOCs) have shown potential to detect PCa. However, their application in disease monitoring remains unexplored. Methods: A total of 165 urine samples were collected from male adults with biopsy-designated PCa-positive results before (n = 55) and after a RP (n = 55), and with biopsy-designated PCa-negative diagnosis (n = 55). The post-RP cohort was subdivided into three groups based on their health status after surgery as recovered healthy, biochemical recurrence, and recurrent metastasis. VOCs in the urine samples were extracted by stir bar sorptive extraction and analyzed using gas chromatography and mass spectrometry. We explored the use of metabolomics and a machine learning algorithm tool to investigate the potential of using VOCs for differentiating PCa diagnoses before and after the RP procedure with different outcomes. Results: Over 100 potential VOCs were identified to differentiate PCa patients before and after a RP, and those with biochemical recurrence and recurrent metastasis. Conclusions: Urinary VOCs are promising biomarkers that could be used to differentiate PCa patients pre- and post-RP. The findings from this research provide preliminary insights and could aid future investigations in developing tools for PCa patients after treatment. The absence of a validation cohort limits the reproducibility and translational impact of these findings; therefore, the results should be considered exploratory and require confirmation in larger, independent cohorts.